The largest database of trusted experimental protocols

Rhace2

Manufactured by R&D Systems
Sourced in China, United States

RhACE2 is a recombinant human Angiotensin-Converting Enzyme 2 (ACE2) protein. ACE2 is a cell surface receptor that binds to the SARS-CoV-2 spike protein, facilitating viral entry into host cells. RhACE2 can be used for research purposes related to the interaction between SARS-CoV-2 and its cellular receptor.

Automatically generated - may contain errors

5 protocols using rhace2

1

Angiotensin Peptide Profiling in Plasma

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum was used to measure blood urea nitrogen, creatinine, sodium, potassium, and chloride concentrations. Plasma was stored at −80°C until batched measurement of equilibrium concentrations of APs, including AT1, AT2, Ang1‐9, Ang1‐7, Ang1‐5, angiotensin 3 (AT3), and angiotensin 4 (AT4), was performed as previously described.18, 19, 20, 22, 26 Briefly, plasma was spiked with stable isotope‐labeled standards for each AP, allowed to reach equilibrium at 37°C, and assayed using liquid chromatography‐tandem mass spectrometry (Attoquant Diagnostics, Vienna, Austria). Use of equilibrium assay avoids the need for special collection and handling requirements at the time of blood collection, increases the signal‐to‐noise ratio of the assay, and results in AP concentrations higher than, but proportional to plasma concentrations using enzyme inhibitors at the time of blood collection.18, 27 To assess the effect of exogenous rhACE2 on the relative concentrations of APs, plasma samples were incubated in vitro with 5 μg/mL of rhACE2 (R&D Systems, Minneapolis, Minnesota) at 37°C, followed by assay of equilibrium concentrations of AT1, AT2, Ang1‐9, Ang1‐7, and Ang1‐5 using previously described methods.18, 19
+ Open protocol
+ Expand
2

Adrenal Angiotensin Peptides and ACE-2 Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Angiotensin peptides were measured in the adrenocortical tissues, in plasma collected during adrenal vein sampling (AVS) from each adrenal vein and from the infrarenal inferior vena cava. These measurements were blindly performed at Attoquant Diagnostics GmbH (Vienna, Austria) with liquid chromatography tandem-mass spectrometry analysis (LC-MS/MS), as described in detail [18 (link)]. The lower limits of detection for these assays are shown in Table 1.
RAS equilibrium analysis was performed in human heparin plasma pool containing 50 ng/ml rhACE-2 (recombinant human ACE-2; R&D Systems, Vienna, Austria) in the presence and absence of 100 μg/ml DIZE (Sigma-Aldrich, Milan, Italy) in order to clarify if DIZE is an allosteric activator of ACE-2 as described [19 (link)].
+ Open protocol
+ Expand
3

Angiotensin Peptide Measurement from Cat Plasma

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum was used to measure BUN, creatinine, sodium, potassium, and chloride. Lithium heparin plasma was stored at −80°C until batched measurement of equilibrium concentrations of APs, including AT1, AT2, Ang1‐9, Ang1‐7, Ang1‐5, angiotensin 3 (AT3), and angiotensin 4 (AT4) was performed as previously described.1, 16, 17, 22, 23 Briefly, plasma was spiked with stable isotope‐labeled standards for each AP, allowed to reach equilibrium at 37°C, and assayed using liquid chromatography‐tandem mass spectrometry (Attoquant Diagnostics, Vienna, Austria). Use of equilibrium assays avoids the need for special collection and handling requirements at the time of blood collection, increases the signal‐to‐noise ratio of the assay, and results in AP concentrations higher than, but proportional to, plasma concentrations using enzyme inhibitors at time of blood collection.16, 24 To assess the effect of exogenous ACE2 on the relative concentrations of selected APs, plasma from cats with CM was assayed after in vitro incubation with 5 μg/mL of rhACE2 (R&D Systems, Minneapolis, Minnesota) at 37°C, followed by measurement of equilibrium concentrations of AT1, AT2, Ang1‐9, Ang1‐7, and Ang1‐5.16, 17
+ Open protocol
+ Expand
4

HUVEC Proliferation and Apoptosis Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
HUVECs (Jennio, China), Dulbecco modified eagle medium (DMEM) with low sugar (Hyclone, USA), fetal serum bovine (FBS, BI, India), penicillin-streptomycin (Bi YT, China), 0.25% pancreatin (Bi YT, China), rhACE2 (R&D Systems, USA), Ang II (Torics, UK), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyletrazolium bromide (MTT) cell proliferation and cytotoxicity assay kit (Sigma, USA), propidium iodide/ribonuclease (PI/RNase) cycle detection kit (BD, USA), fluorescein isothiocyanate (FITC) annexin V apoptosis detection kit 1 (BD, USA), reactive oxygen species (ROS) detection kit (Bi YT, China), interleukin (IL)-8 enzyme-linked immunosorbent assay (ELISA) kit (R&D, USA), tumor necrosis factor α (TNF-α) ELISA kit (R&D, USA), transforming growth factor-β1 (TGF-β1) ELISA kit (Abcam, USA), lactate dehydrogenase (LDH) ELISA kit (Jiancheng, China). HF90/HF240 cell incubator (Heal Force, China), Multiskan GO 1510 spectrophotometer (Thermo Fisher, USA), BD FACS Aria III flow cytometer (BD, USA).
+ Open protocol
+ Expand
5

SARS-CoV-2 Spike Protein Binding Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant SARS-CoV-2 S-proteins, SW, SD, rhACE2, rTFPI, and TM (BDCA3), were purchased from R&D Systems (Minneapolis, MN, USA). DTNB was from Sigma-Aldrich (St. Louis, MO, USA). Anti-human CD66b and anti-human CD45 antibodies were from Stemcell Technologies (Cambridge, MA, USA); anti-human CD16 antibodies were from Ancell Corporation (Stillwater, MN, USA). Monoclonal P-selectin antibodies and DAPI were from Thermo Fisher/Invitrogen (Waltham, MA, USA), and β-actin antibodies were from Santa Cruz Biotechnology (Dallas, TX, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!